CORRESPONDENCE COLUMNS
|
|
- Allan Gilbert
- 5 years ago
- Views:
Transcription
1 POSTPUBLICATION ISSUES Postpublication Criticism and the Shaping of Clinical Knowledge Richard Horton, FRCP CORRESPONDENCE COLUMNS provide an important place for comments, questions, and criticisms of work published in journals. The International Committee of Medical Journal Editors 1 has declared that all biomedical journals should have such a section because the absence of one denies readers the possibility of responding to articles in the same journal that published the original work. Editors of leading journals have repeatedly endorsed this view. 2-4 Yet there is a strain of skepticism about letters to the editor. As one commentator noted, Criticism is a challenge to be overcome, usually by a mixture of semantic wrigglings, ignoring the main point but expansively countering less important ones...and sometimes by being implicitly abusive. 5 A contrary view is that published correspondence is part of the continual process of peer review. How important is such postpublication criticism in shaping clinical knowledge? METHODS My aim was to complete a preliminary study of the critical footprint made in the medical literature by 3 research studies published in The Lancet: the Hypertension Optimal Treatment (HOT) trial, 6 the Captopril Prevention Project (CAPPP), 7 and the Swedish Trial in Old Patients with Hypertension 2 (STOP- 2). 8 These studies were selected because they were likely to have a substantial impact on clinical practice. I also wanted to investigate the extent to which their critical footprints were preserved in the subsequent shaping of Context Letters to the editor are an important means for ensuring accountability of authors and editors. They form a part of the postpublication peer review process. I studied the critical footprint made in the medical literature by 3 randomized trials (Hypertension Optimal Treatment [HOT], Captopril Prevention Project [CAPPP], and Swedish Trial in Old Patients with Hypertension 2 [STOP-2]) published in The Lancet and investigated the extent to which that footprint was preserved in shaping clinical knowledge. Methods Qualitative appraisal of the criticism of each trial, taken from published letters. Agreed weaknesses and unanswered criticisms were identified from the authors reply. I searched MEDLINE for practice guidelines published after the trial report and sought evidence for incorporation of criticism into these guidelines. Results From the time of publication to October 2000, HOT was cited in 9 of 36 practice guidelines; CAPPP, in 6 of 36; and STOP-2, not at all. HOT received 14 published criticisms, 5 comments, and 3 questions, of which 15 were responded to. Only 1 criticism, lack of power, was referred to in 1 guideline. CAPPP received 14 criticisms, 9 comments, and 3 questions, of which 8 were responded to. Only 1 criticism, imbalances between groups, was referred to in 1 guideline. STOP-2 received 12 criticisms, 9 comments, and 3 questions, of which only 6 were responded to. Conclusions More than half of all criticism made in correspondence went unanswered by authors. Important weaknesses in trials were ignored in subsequently published practice guidelines. Failure to recognize the critical footprint of primary research weakens the validity of guidelines and distorts clinical knowledge. JAMA. 2002;287: clinical knowledge about hypertension treatment. Letters to The Lancet are collected in the 8 weeks following publication of the original article. They are read by a correspondence editor and me, and we share the decision about what to publish. Our aim is to print important criticism without duplication. About half of all letters received are published. For each study, I prepared a taxonomy of criticism from the letters published in the journal. In each case, the authors were invited to respond to correspondents. No specific guidance was given to the original authors of each trial about how to prepare their response. I devised a list of agreed weaknesses and unanswered criticisms. Next, I searched under the following key words in the MEDLINE database for practice guidelines published from June 13, 1998, through October 25, 2000, after the initial randomized trial report: hypertension, English, human, meta-analysis, and guideline. Finally, I sought evidence for the incorporation of these criticisms into the interpretations of trials discussed in these guidelines. RESULTS Hypertension Optimal Treatment Trial This randomized trial set out to assess the optimum target diastolic blood pressure in hypertensive patients. In the published correspondence, 9 14 criticisms were made, 5 comments offered, and 3 questions asked (BOX 1). The HOT Author Affiliation: Dr Horton is Editor of The Lancet, London, England. Corresponding Author and Reprints: Richard Horton, FRCP, The Lancet, 32 Jamestown Rd, London NW17BY, England ( richard.horton@lancet.com) American Medical Association. All rights reserved. (Reprinted) JAMA, June 5, 2002 Vol 287, No
2 Box 1. Published,, and About the Hypertension Optimal Treatment (HOT) Trial * Precision of blood pressure measurements was not given * Method of blood pressure measurement produces distortion Aspirin treatment may introduce bias Intention-to-treat analysis shows no advantage to low diastolic blood pressure The HOT trial was stopped early, well below target number of events * A total of 114 events were not validated * Different antihypertensive agents may produce different outcomes * Original main end point was not used Results do not justify the conclusion about a lower target blood pressure * Estimate of optimum blood pressure did not take into account baseline values Analysis of nondiabetic population confirms the J-shaped curve * Marginal clinical benefits do not justify costs * Data are not corrected for placebo treatment * Patients at highest risk were excluded More prescriptions will mean higher costs * Extrapolation of benefits is fraught with difficulty * Interpretation is compatible with caution over aggressive blood pressure reduction * Recommendation for a particular drug regimen in hypertensive patients with diabetes Comparison with one other randomized trial * Does lack of data about pulse pressure affect the interpretation of the HOT trial? * What were the outcomes in patients with a history of ischemic heart disease? * What were the outcomes among patients who achieved their target blood pressure? * investigators responded to 8 criticisms, replied to 4 comments, and answered all 3 questions. They acknowledged 3 weaknesses in their study. First, their data were incomplete, partly because editors wished to exclude information to reduce the article s length. Second, they were unable to separate the effects on outcomes for individual drugs. Third, the HOT study has not definitively solved all the problems it set out to investigate. 6 Important potential problems were left undiscussed (eg, the accuracy of blood pressure measurement, the omission of the study s main end point, and the report s generalizability to patients most at risk). The HOT report was cited in 9 of 36 practice guidelines published between August 1998 and October These guidelines included 3 versions (long and short) of the World Health Organization/International Society of Hypertension (WHO/ISH) guidelines on management of hypertension, 2 versions (1 complete) of guidelines from the British Hypertension Society, and 1 full version each of joint British recommendations, Canadian guidelines, Japanese guidelines for hypertension in the elderly, and a consensus document on preserving renal function in adults with hypertension (a reference list can be obtained from the author). In only 1 practice guideline did 1 criticism, lack of power, which was not cited in The Lancet correspondence, surface in discussion of the trial report. 10 Captopril Prevention Project This randomized trial compared the effects of angiotensin-converting enzyme inhibition with that of conventional therapy on cardiovascular morbidity and mortality in more than patients with hypertension. In the published correspondence, criticisms were made, 9 comments offered, and 3 questions asked (BOX 2). The CAPPP investigators responded to 5 criticisms, replied to 2 comments, and answered 1 question. They acknowledged 3 weaknesses in their study. First, the dosing schedule of captopril was inferior. Second, insulin sensitivity, their proposed mechanism to explain fewer cases of diabetes in patients taking captopril, was unlikely. Third, different treatments seemed to produce different patterns of clinical effects, which they were unable to separate. A large number of important issues were left undiscussed (eg, about post hoc analyses, mean doses of drugs given, cost of treatments, and the clinical implications of the study). The CAPPP study was cited in 6 of 36 practice guidelines published between August 1998 and October These guidelines included 3 versions of the WHO/ISH guidelines on management of hypertension, 2 versions (1 long, 1 short) of guidelines from the British Hypertension Society, and 1 set of Canadian recommendations. In only 1 of these guidelines was a criticism acknowledged and discussed. The WHO/ ISH guidelines refer to imbalances in the assignment of treatment. 12 Swedish Trial in Old Patients With Hypertension 2 This clinical trial aimed to compare the effects of conventional vs newer antihypertensive drugs on cardiovascular mortality and morbidity in 6614 elderly patients between the ages of 70 and 84 years. In the published correspondence, criticisms were made, 9 comments offered, and 3 questions asked (BOX 3). The STOP-2 investigators responded to 4 criticisms, replied to 1 comment, and answered 1 question. They acknowledged no weaknesses in their study. Substantial clinical and methodologic issues were left unanswered (eg, issues surrounding reporting of adverse drug reactions, differences between in JAMA, June 5, 2002 Vol 287, No. 21 (Reprinted) 2002 American Medical Association. All rights reserved.
3 dividual drugs, and end-point reporting). No practice guidelines had incorporated the results of STOP-2, most likely because insufficient time had elapsed for the study to be included. The overall response rate in HOT, CAPPP, and STOP-2 to criticisms, comments, and questions was 40%. Box 2. Published,, and About the Captopril Prevention Project (CAPPP) Trial * The dosing schedule of captopril was inadequate * Angiotensin-converting enzyme inhibitor therapy may be harmful Trial design was open * Randomization led to important imbalances between groups * Mean daily doses of drugs are missing Details of combined treatments are not given Cost comparisons are not provided Inclusion criteria are violated Changes in blood pressure are not specified Reliability of screening for diabetes is questioned Post hoc analyses are unreliable Statements about clinical implications are premature The stroke risk increases with captopril therapy * In considering implications, the stroke rate cannot be ignored * Diuretics and -blockers remain first-line treatment Angiotensin-converting enzyme inhibitors are add-on, not monotherapy It is hard to compare CAPPP with the United Kingdom Prospective Diabetes Study Diabetes incidence was low in this population Reduction in diabetes was unrelated to insulin sensitivity * CAPPP is difficult to interpret Different outcomes would be expected from different drug classes * Excess strokes are still present after adjusted analysis One could compare stroke events in databases Which patients received -blockers as initial treatments? Which patients received diuretics as initial treatments? Was the outcome influenced by choice of drug? * COMMENT This preliminary study shows that research reports leave deep critical footprints in the medical literature. Yet more than half of all criticisms made in letters went unanswered by authors. Important weaknesses in these trials were ignored in subsequently published practice guidelines. The failure to preserve the critical footprint left by a research article weakens the validity of guidelines and distorts clinical knowledge. This study suggests that criticism is undervalued by both the medical research and practice communities. The limitations of this study are at least 2-fold. First, this was an exploratory investigation: only a small number of trials were chosen, and these were taken from one journal. Second, the quality of the criticisms was not independently validated. Nevertheless, these observations point to important questions not only about the peer-review process in scientific research, but also about the validity of our clinical knowledge. The weaknesses of existing peerreview processes at medical journals have been described before. For example, Rothwell and Martyn 14 found that reproducibility among peer reviewers of clinical neuroscience journals was poor. Journal editors have recognized these problems, and a few have tried to devise ways to enhance the reliability of their peer-review processes. Some of the most innovative work has been conducted at the Medical Journal of Australia. Editors at the Medical Journal of Australia had found that readers were not taking full advantage of the opportunity for postpublication peer review provided by correspondence columns in the journal. 15 They have used the Internet to widen the peer-review process and encourage greater interaction between readers and authors. 16,17 The Lancet 18 and BMJ 19 have tried a different approach. Beginning in July 1999 and December 1999, respectively, these journals introduced electronic preprint servers. Although widely discussed and advertised, few authors have elected to submit work to either preprint service. Preprint servers widen the opportunities for publication, broaden the range of voices taking part in medical debates (notably, from developing countries 20 and patients), and promote scientific innovation by removing what can be the profoundly conservative barrier of peer review. 21 However, skeptical voices have questioned the freedom provided by open discussion on the Internet. The editor of the British Journal of Obstetrics and Gynaecology has described the Internet as a kangaroo court and a nightmare world. 22 Despite these innovative means to widen the peer-review process, which have largely failed to live up to early hopes, letters to the editor are likely to remain the mainstay of holding authors accountable for their work. Editors and authors must therefore work harder to ensure that authors respond fully to important criticism. Editors at The Lancet leave decisions about how authors should reply to criticism of their work to the authors themselves. The balance of power leans too far in the authors favor. We could do a great deal more to make sure that criticism is taken account of appropriately in postpublication peer review. This study also raises 2002 American Medical Association. All rights reserved. (Reprinted) JAMA, June 5, 2002 Vol 287, No
4 Box 3. Published,, and About the Swedish Trial in Old Patients With Hypertension 2 (STOP-2) Trial * STOP-2 was not designed to compare individual drugs * There are missing data about how many patients received -blockers and diuretics Pindolol is harmful STOP-2 was an open trial * Adverse drug reaction reporting was invalid There are biased reports of end points A masked end-point committee does not rule out bias True differences between drugs are obscured by combinations and crossovers * The conclusion concerning equivalence is incorrect * There is heterogeneity among treatment groups Cox regression analysis may show an inconclusive result Randomization has produced bias regarding diabetes rates Physicians must wait for trials of drugs, not strategies Future practice depends on the results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Wide pulse pressures may explain higher frequencies of end points Conventional antihypertensive drugs may not be good enough The only valid comparison is between combinations A surprisingly large decrease in blood pressure was seen despite only dual therapy Calcium channel blockers are equivalent to other antihypertensive drugs Higher rates of myocardial infarction with calcium channel blockers are disturbing * Dose frequency of isradipine may have been wrong Did myocardial infarctions occur more frequently in the mornings? Were there any differences in heart rate between groups? Could results of the ABCD trial be reproduced in STOP-2? * questions about the basis of clinical knowledge. Following the work of Popper, 23 scientific knowledge accumulates according to the resistance of hypotheses to falsification. This test, Popper argued, is a more useful way to judge the success of a scientific theory than verification. Yet it was John Stuart Mill who laid the philosophical groundwork to understand the importance of criticism in shaping knowledge. In On Liberty, 24 he anticipated Popper when he wrote, The beliefs which we have most warrant for have no safeguard to rest on but a standing invitation to the whole world to prove them unfounded. Specifically, knowledge depends on fostering a culture of criticism: However unwillingly a person who has a strong opinion may admit the possibility that his opinion may be false, he ought to be moved by the consideration that, however true it may be, if it is not fully, frequently, and fearlessly discussed, it will be held as a dead dogma, not a living truth. The practical importance of this view is direct, according to Mill: Complete liberty of contradicting and disproving our opinion is the very condition which justifies us in assuming its truth for purposes of action; and on no other terms can a being with human faculties have any rational assurance of being right. Indeed, formal letter writing to journals is now used in some medical curricula to teach critical appraisal skills. 25 In sum, criticism in letters to the editor is a neglected genre of writing. Letters enable free expression of opinion, reveal the intellectual vigor of the community concerned, and help shape knowledge. This study suggests that there is a resistance to criticism in medical research. The randomized trial is the best means medicine has to secure reliable knowledge about interventions. However, the label randomized trial seems to have blunted our desire to think critically when devising practice guidelines. Editors could do a great deal more to ensure proper accountability to criticism. In addition, editors could help further by adopting a preventive role: to encourage authors to publish fuller and longer articles, perhaps by taking advantage of the Internet, that anticipate likely criticism. Author Contributions: Richard Horton conceived, designed, conducted, analyzed, and wrote this study. Acknowledgment: I am grateful to Hopelyn Goodwin, who provided secretarial assistance. REFERENCES 1. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Available at: Accessibility verified March 22, Bhopal RS, Tonks A. The role of letters in reviewing research. BMJ. 1994;308: Brown CJ. Unvarnished viewpoints and scientific scrutiny. CMAJ. 1997;157: Winker MA, Fontanarosa PB. Letters: a forum for scientific discourse. JAMA. 1999;281: Goodman NW. How to write a critical letter and respond to one. Hosp Med. 2001;62: Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and lowdose aspirin in patients with hypertension. Lancet. 1998;351: Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999;353: Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999;354: Simon A, Levenson J, Avanzini F, et al. Hypertension Optimal Treatment (HOT) trial. Lancet. 1998; 352: Ramsay LE, Williams B, Johnston GD, et al. British Hypertension Society Guidelines for hypertension management BMJ. 1999;319: Lim PO, Scheen AJ, Wiggam MI, et al. CAPPP trial. Lancet. 1999;353: Guidelines Subcommittee World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Clin Exp Hypertens. 1999;21: Fuchs FD, Wang JG, Gasowski J, et al. What does STOP-2 tell us about management of hypertension? Lancet. 2000;355: Rothwell PM, Martyn CN. Reproducibility of peer 2846 JAMA, June 5, 2002 Vol 287, No. 21 (Reprinted) 2002 American Medical Association. All rights reserved.
5 FACTORS ASSOCIATED WITH POSTPUBLICATION CITATION review in clinical neuroscience. Brain. 2000;123: Caswell A. Letters to the editor Med J Aust. 1992;157: Bingham C. Peer review on the Internet: a better class of conversation. Lancet. 1998;351(suppl 1): Bingham CM, Higgins G, Coleman R, Van der Weyden MB. The Medical Journal of Australia Internet peer-review study. Lancet. 1998;352: McConnell J, Horton R. Lancet electronic research archive in international health and eprint server. Lancet. 1999;354: Smith R. Electronic publishing in science. BMJ. 2001;322: Horton R. North and South: bridging the information gap. Lancet. 2000;355: Horrobin DF. The philosophical basis of peer review and the suppression of innovation. JAMA. 1990; 263: Grant JM. Timely publication of critical letters. Lancet. 1999;353: Popper K. Realism and the Aim of Science. London, England: Routledge; Mill JS. On Liberty. London, England: Penguin; Edwards R, White M, Gray J, Fischbacher C. Use of a journal club and letter-writing exercise to teach critical appraisal to medical undergraduates. Med Educ. 2001;35: Journal Prestige, Publication Bias, and Other Characteristics Associated With Citation of Published Studies in Peer-Reviewed Journals Michael Callaham, MD Robert L. Wears, MD, MS Ellen Weber, MD ALTHOUGH PUBLICATION IS A crucial portion of the scientific process, an equally important part is the subsequent use and citation of these published articles by other researchers and authors. We studied a cohort of all research submitted to a scientific meeting and subsequently published to determine how these studies were cited by other authors and determine what characteristics (including positive results) were associated with more frequent citation. METHODS We previously reported the methods of the first phase of this study. 1 To summarize, all abstracts of scientific studies submitted to the Society for Academic Emergency Medicine (SAEM) meeting in 1991 were examined. Each submitted abstract was categorized in a blinded fashion according to research design, number of subjects, and other characteristics (TABLE 1 and Context Citation by other authors is important in the dissemination of published science, but factors predicting it are little studied. Methods To identify characteristics of published research predicting citation in other journals, we searched the Science Citations Index database for a standardized 3.5 years for all citations of published articles originally submitted to a 1991 emergency medicine specialty meeting. Analysis was conducted by classification and regression trees, a nonparametric modeling technique of regression trees, to determine the impact of previously determined characteristics of the full articles on the outcome measures. We calculated the the number of times an article was cited each year and calculated the mean impact factor (citations per manuscript per year) in other citing journals. Results Of the 493 submitted manuscripts, 204 published articles met entry criteria. The mean citations per year was 2.04 (95% confidence interval, ; range, ) in 440 different journals. Nineteen articles (9.3%) were never cited. The ability to predict the citations per year was weak (pseudo R 2 =0.14.). The strongest predictor of citations per year was the impact factor of the original publishing journal. The presence of a control group, the subjective newsworthiness score, and sample size predicted citation frequency (24.3%, 26.0%, and 26.5% as strongly, respectively). The ability to predict mean impact factor of the citing journals was even weaker (pseudo R 2 =0.09). The impact factor of the publishing journal was the strongest predictor, followed by the newsworthiness score (89.9% as strongly) and a subjective quality score (61.5%). Positive outcome bias was not evident for either outcome measure. Conclusion In this cohort of published research, commonly used measures of study methodology and design did not predict the frequency of citations or the importance of citing journals. Positive outcome bias was not evident. The impact factor of the original publishing journal was more important than any other variable, suggesting that the journal in which a study is published may be as important as traditional measures of study quality in ensuring dissemination. JAMA. 2002;287: Author Affiliations: Division of Emergency Medicine, University of California, San Francisco (Drs Callaham and Weber), Department of Emergency Medicine, University of Florida at Jacksonville, Jacksonville (Dr Wears). Corresponding Author and Reprints: Michael Callaham, MD, Box 0208, University of California, San Francisco, CA ( mlc@medicine.ucsf.edu) American Medical Association. All rights reserved. (Reprinted) JAMA, June 5, 2002 Vol 287, No
Citation Characteristics of Research Published in Emergency Medicine Versus Other Scientific Journals
ORIGINAL CONTRIBUTION Citation Characteristics of Research Published in Emergency Medicine Versus Other Scientific From the Division of Emergency Medicine, University of California, San Francisco, CA *
More informationWhat do letters to the editor publish about randomized controlled trials? A cross-sectional study
Kastner et al. BMC Research Notes 2013, 6:414 RESEARCH ARTICLE Open Access What do letters to the editor publish about randomized controlled trials? A cross-sectional study Monika Kastner 1*, Anita Menon
More informationThe problem of uncontrolled hypertension
(2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands
More informationSystematic Reviews. Simon Gates 8 March 2007
Systematic Reviews Simon Gates 8 March 2007 Contents Reviewing of research Why we need reviews Traditional narrative reviews Systematic reviews Components of systematic reviews Conclusions Key reference
More informationALLHAT Investigators Report 10-Year Follow-up and Stand by Diuretics as First-Step Antihypertensive Treatment
1 sur 5 21/11/2009 07:26 www.medscape.com Medscape Medical News from the: American Heart Association (AHA) 2009 Scientific Sessions This coverage is not sanctioned by, nor a part of, the American Heart
More informationImproving Medical Statistics and Interpretation of Clinical Trials
Improving Medical Statistics and Interpretation of Clinical Trials 1 ALLHAT Trial & ALLHAT Meta-Analysis Critique Table of Contents ALLHAT Trial Critique- Overview p 2-4 Critique Of The Flawed Meta-Analysis
More informationCedars Sinai Diabetes. Michael A. Weber
Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives
Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme
More informationBlood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ
1 Blood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ 2016.033440 Dear Editor, Editorial Committee and Reviewers Thank you for your appreciation
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationBy Prof. Khaled El-Rabat
What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationLearning objectives. Examining the reliability of published research findings
Examining the reliability of published research findings Roger Chou, MD Associate Professor of Medicine Department of Medicine and Department of Medical Informatics and Clinical Epidemiology Scientific
More informationA Reply to the Commentators on the Ethical Dilemmas Study,
Maurice A. Deane School of Law at Hofstra University Scholarly Commons at Hofstra Law Hofstra Law Faculty Scholarship 1994 A Reply to the Commentators on the Ethical Dilemmas Study, Robert A. Baruch Bush
More informationTiming Your Research Career & Publishing Addiction Medicine
Timing Your Research Career & Publishing Addiction Medicine Jeffrey H. Samet, MD, MA, MPH Chief, General Internal Medicine John Noble MD Professor in General Internal Medicine & Professor of Public Health
More informationPublishing Your Study: Tips for Young Investigators. Learning Objectives 7/9/2013. Eric B. Bass, MD, MPH
Publishing Your Study: Tips for Young Investigators Eric B. Bass, MD, MPH Learning Objectives To apply a logical approach to organizing & presenting your work in a manuscript To recognize the importance
More informationBlind Manuscript Submission to Reduce Rejection Bias?
Sci Eng Ethics DOI 10.1007/s11948-014-9547-7 OPINION Blind Manuscript Submission to Reduce Rejection Bias? Khaled Moustafa Received: 10 March 2014 / Accepted: 3 April 2014 Ó Springer Science+Business Media
More informationReviewer s report. Version: 0 Date: 17 Dec Reviewer: Julia Marcus. Reviewer's report:
Reviewer s report Title: Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with human immunodeficiency virus (HIV)?: a cohort collaboration
More informationResponse to the ASA s statement on p-values: context, process, and purpose
Response to the ASA s statement on p-values: context, process, purpose Edward L. Ionides Alexer Giessing Yaacov Ritov Scott E. Page Departments of Complex Systems, Political Science Economics, University
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationReplicating Randomised Trials of Treatments in Observational Settings Using Propensity Scores Fisher s Aphorisms
Replicating Randomised Trials of Treatments in Observational Settings Using Propensity Scores Fisher s Aphorisms Nick Freemantle PhD Professor of Clinical Epidemiology & Biostatistics Assessing Causation
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationCRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE
CRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE MINGGU PENYELIDIKAN PERUBATAN & KESIHATAN PPUKM Lecture content Introduction
More informationVolume 2 Number 2 (2011)
Review of Global Medicine and Healthcare Research Volume 2 Number 2 (211) Publisher: DRUNPP Managed by: IOMC Group Website: www.iomcworld.com/rgmhr/ Drug Utilization Pattern and Co-morbidtities Among Hypertensive
More informationDRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU
Original Article DRUG UTILIZATION PATTERNS OF ANTIHYPERTENSIVES IN VARIOUS WARDS IN A TERTIARY CARE HOSPITAL IN TAMILNADU V.Gowri 1, K.Punnagai, K.Vijaybabu 3, Dr.Darling Chellathai 4 1 Assistant Professor
More informationMetformin should be considered in all patients with type 2 diabetes unless contra-indicated
November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients
More informationEVMS Authorship Guidelines
EVMS Authorship Guidelines Many medical schools, including Eastern Virginia Medical School, encourage the publication and dissemination of results from research and other scholarly activities in a manner
More informationAn introduction to power and sample size estimation
453 STATISTICS An introduction to power and sample size estimation S R Jones, S Carley, M Harrison... Emerg Med J 2003;20:453 458 The importance of power and sample size estimation for study design and
More informationWhy published medical research may not be good for your health
Why published medical research may not be good for your health Doug Altman EQUATOR Network and Centre for Statistics in Medicine University of Oxford 2 Reliable evidence Clinical practice and public health
More informationEssential Skills for Evidence-based Practice Understanding and Using Systematic Reviews
J Nurs Sci Vol.28 No.4 Oct - Dec 2010 Essential Skills for Evidence-based Practice Understanding and Using Systematic Reviews Jeanne Grace Corresponding author: J Grace E-mail: Jeanne_Grace@urmc.rochester.edu
More informationThe importance of good reporting of medical research. Doug Altman. Centre for Statistics in Medicine University of Oxford
The importance of good reporting of medical research Doug Altman Centre for Statistics in Medicine University of Oxford 1 Why reporting matters CONSORT and other reporting guidelines EQUATOR Network Other
More informationEFFECTIVE MEDICAL WRITING Michelle Biros, MS, MD Editor-in -Chief Academic Emergency Medicine
EFFECTIVE MEDICAL WRITING Michelle Biros, MS, MD Editor-in -Chief Academic Emergency Medicine Why We Write To disseminate information To share ideas, discoveries, and perspectives to a broader audience
More informationBritish Geriatrics Society
Healthcare professional group/clinical specialist statement Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare
More informationPharmacotherapy for Alcohol Dependence
Evidence Report/Technology Assessment: Number 3 Pharmacotherapy for Alcohol Dependence Summary Under its Evidence-Based Practice Program, the Agency for Health Care Policy and Research (AHCPR) is developing
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationExecutive Summary. Different antihypertensive drugs as first line therapy in patients with essential hypertension 1
IQWiG Reports Commission No. A05-09 Different antihypertensive drugs as first line therapy in patients with essential hypertension 1 Executive Summary 1 Translation of the executive summary of the final
More informationHow do we identify a good healthcare provider? - Patient Characteristics - Clinical Expertise - Current best research evidence
BSC206: INTRODUCTION TO RESEARCH METHODOLOGY AND EVIDENCE BASED PRACTICE LECTURE 1: INTRODUCTION TO EVIDENCE- BASED MEDICINE List 5 critical thinking skills. - Reasoning - Evaluating - Problem solving
More informationCJSP: On Reaffirming a Canadian School Psychology
748212CJSXXX10.1177/0829573517748212Canadian Journal of School PsychologyEditorial editorial2017 Editorial CJSP: On Reaffirming a Canadian School Psychology Canadian Journal of School Psychology 1 5 The
More informationInterested parties (organisations or individuals) that commented on the draft document as released for consultation.
23 June 2016 EMA/CHMP/345847/2015 Committee for Medicinal products for Human Use Overview of comments received on ''Guideline on clinical investigation of medicinal products in the treatment of hypertension'
More informationEvidence-based Laboratory Medicine: Finding and Assessing the Evidence
Find Assess Decide Evidence-based Laboratory Medicine: Finding and Assessing the Evidence Pieter Vermeersch, M.D. Ph.D. Laboratory Medicine, UZ Leuven November 18th 2008 Introduction Archie Cochrane (1908-1988)
More informationConfidence Intervals On Subsets May Be Misleading
Journal of Modern Applied Statistical Methods Volume 3 Issue 2 Article 2 11-1-2004 Confidence Intervals On Subsets May Be Misleading Juliet Popper Shaffer University of California, Berkeley, shaffer@stat.berkeley.edu
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationFirst line treatment of primary hypertension
First line treatment of primary hypertension Dr. Vijaya Musini Assistant Professor, Dept. Anesthesiology, Pharmacology and Therapeutics Manager, Drug Assessment Working Group Therapeutics Initiative Editor,
More informationThe Role of Systematic Reviews
The Role of Systematic Reviews Can Systematic Review of Preclinical Data Assist with Replacement, Refinement, and Reduction of Animal Use in Neuroscience Research? Anne N. Murphy, Ph.D. Dept of Pharmacology
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationUses and misuses of the STROBE statement: bibliographic study
Uses and misuses of the STROBE statement: bibliographic study Bruno R. da Costa 1, Myriam Cevallos 1, 2, Douglas G. Altman 3, Anne W.S. Rutjes 1, Matthias Egger 1 1. Institute of Social & Preventive Medicine
More informationQuality of Clinical Practice Guidelines
Evidence Based Dentistry Quality of Clinical Practice Guidelines Asbjørn Jokstad University of Oslo, Norway 07/04/2005 1 Justification for developing guidelines Demand for effectiveness and efficacy studies
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More information13 Research for the right reasons: blueprint for a better future
Chapter 13 13 Research for the right reasons: blueprint for a better future Medical research has undoubtedly contributed to better quality of life and increased longevity. Nevertheless, we have illustrated
More informationOutline. Bioethics in Research and Publication. What is ethics? Where do we learn ethics? 6/19/2015
Outline Bioethics in Research and Publication Gertrude Night, PhD Rwanda Agriculture Board What is ethics? History. The purpose of training in research ethics Some ethical principles addressed by research
More informationOnline Supplementary Material
Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationSchool of Dentistry. What is a systematic review?
School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical
More informationAcute Dialysis Quality Inititative 8 th Scientific Meeting: Hepatorenal Syndrome March 16 th -19 th, 2010
Acute Dialysis Quality Inititative 8 th Scientific Meeting: Hepatorenal Syndrome March 16 th -19 th, 2010 Acute Dialysis Quality Initiative (ADQI) started in response to concerns about the quality of care
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of the
More informationGuidelines for Writing and Reviewing an Informed Consent Manuscript From the Editors of Clinical Research in Practice: The Journal of Team Hippocrates
Guidelines for Writing and Reviewing an Informed Consent Manuscript From the Editors of Clinical Research in Practice: The Journal of Team Hippocrates 1. Title a. Emphasize the clinical utility of the
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationKnowledge and perceptions of physicians about Evidence Based Management of hypertension in acute ischemic stroke patients
Original Article Knowledge and perceptions of physicians about Evidence Based Management of hypertension in acute ischemic stroke patients ABSTRACT Objective Naveeda Khaliq, Nausheen Hussain, Rabia Akhter,
More informationCochrane Breast Cancer Group
Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.
More informationDATE: 04 April 2012 CONTEXT AND POLICY ISSUES
TITLE: Procedure Site Bleeding Complications Following Percutaneous Coronary Interventions or Angioplasty: A Review of Clinical Evidence and Guidelines DATE: 04 April 2012 CONTEXT AND POLICY ISSUES Percutaneous
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More informationREDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT
REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT Vida Stankus 1, Brenda Hemmelgarn 2, Norm RC Campbell 2, Guanmin Chen 2, Finlay A McAlister 1, Ross T Tsuyuki 1 1 EPICORE Centre, Department of Medicine,
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationIn the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi
Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients? Commentary on Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators.
More informationHow clinically important are the results of the large trials in hypertension?
How clinically important are the results of the large trials in hypertension? Stéphane LAURENT, MD, PhD, FESC Pharmacology Department and PARCC / INSERM U970 Hôpital Européen Georges Pompidou, Université
More informationSkillBuilder Shortcut: Levels of Evidence
SkillBuilder Shortcut: Levels of Evidence This shortcut sheet was developed by Research Advocacy Network to assist advocates in understanding Levels of Evidence and how these concepts apply to clinical
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationClinical Guidelines And Primary Care
Clinical Guidelines And Primary Care Alfred O. Berg, MD, MPH, Series Editor Screening For Adolescent Idiopathic Scoliosis: A Report From The United States Preventive Services Task Force Alfred O. Berg,
More informationINTERNAL VALIDITY, BIAS AND CONFOUNDING
OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationThere is convincing evidence in clinical studies
AJH 1998;11:1413 1417 Reliability of Reporting Self-Measured Blood Pressure Values by Hypertensive Patients Thomas Mengden, Rosa Maria Hernandez Medina, Belen Beltran, Elena Alvarez, Karin Kraft, and Hans
More informationAAEM Clinical Practice Committee Statement Literature Search / Grading Process - Revision Version 3.0 September 2011
Rationale: The process by which literature searches are performed to evaluate specific clinical questions can be quite labor intensive. Data which is most informative to clinical practice will often be
More informationAOTA S EVIDENCE EXCHANGE CRITICALLY APPRAISED PAPER (CAP) GUIDELINES Annual AOTA Conference Poster Submissions Critically Appraised Papers (CAPs) are
AOTA S EVIDENCE EXCHANGE CRITICALLY APPRAISED PAPER (CAP) GUIDELINES Annual AOTA Conference Poster Submissions Critically Appraised Papers (CAPs) are at-a-glance summaries of the methods, findings and
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationClinical Practice Committee Statement Protocols (updated 2/22/2018) Henry Kim, MD FAAEM William Meurer, MD FAAEM. Steven Rosenbaum, MD FAAEM
Clinical Practice Committee Statement Protocols (updated 2/22/2018) Chair: Authors: Steven Rosenbaum, MD FAAEM Henry Kim, MD FAAEM William Meurer, MD FAAEM Steven Rosenbaum, MD FAAEM Instructions for Authors
More informationWebinar 3 Systematic Literature Review: What you Need to Know
Webinar 3 Systematic Literature Review: What you Need to Know Camille Kolotylo RN, PhD Andrea Baumann RN, PhD Nursing Health Services Research Unit (NHSRU) McMaster University Date: Thursday May 29, 2014
More informationAbout the Article. About the Article. Jane N. Buchwald Viewpoint Editor
Do Bariatric Surgeons and Co-Workers Have An Adequate Working Knowledge of Basic Statistics? Is It Really Important? Really Important? George Cowan, Jr., M.D., Professor Emeritus, Department of Surgery,
More informationEvidence-based medicine and guidelines: development and implementation into practice
Evidence-based medicine and guidelines: development and implementation into practice PD Dr D. Aujesky, MSc MER Médecin-adjoint Service de Médecine Interne CHUV 1 Goals To discuss the basics of evidence-based
More informationPrinciples of publishing
Principles of publishing Issues of authorship, duplicate publication and plagiarism in scientific journal papers can cause considerable conflict among members of research teams and embarrassment for both
More informationFROM A QUESTION TO A PAPER
FROM A QUESTION TO A PAPER Dr. Naima K. Al Bulushi, MD, FFR RCSI HOD, Nuclear medicine department and Molecular Imaging Centre, Muscat, Oman Arab Society of Nuclear Medicine (ARSNM) MAIN TOPICS A) Research;
More informationTransparency and accuracy in reporting health research
Transparency and accuracy in reporting health research Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK Transparency and value Research only has value if Study methods have
More informationMeasuring and Assessing Study Quality
Measuring and Assessing Study Quality Jeff Valentine, PhD Co-Chair, Campbell Collaboration Training Group & Associate Professor, College of Education and Human Development, University of Louisville Why
More informationCONSORT 2010 Statement Annals Internal Medicine, 24 March History of CONSORT. CONSORT-Statement. Ji-Qian Fang. Inadequate reporting damages RCT
CONSORT-Statement Guideline for Reporting Clinical Trial Ji-Qian Fang School of Public Health Sun Yat-Sen University Inadequate reporting damages RCT The whole of medicine depends on the transparent reporting
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationCauses of Poor BP control Rates
Goals Of Hypertension Management in Clinical Practice World Hypertension League (WHL) Meeting Adel E. Berbari, MD, FAHA, FACP Professor of Medicine and Physiology Head, Division of Hypertension and Vascular
More informationCHAMP: CHecklist for the Appraisal of Moderators and Predictors
CHAMP - Page 1 of 13 CHAMP: CHecklist for the Appraisal of Moderators and Predictors About the checklist In this document, a CHecklist for the Appraisal of Moderators and Predictors (CHAMP) is presented.
More informationAspirin to Prevent Heart Attack and Stroke: What s the Right Dose?
The American Journal of Medicine (2006) 119, 198-202 REVIEW Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose? James E. Dalen, MD, MPH Professor Emeritus, University of Arizona, Tucson
More informationSystematic Reviews and Meta-analysis
Systematic Reviews and Meta-analysis Introduction to Clinical Research: A Two-week Intensive Course July 22, 2014 Sonal Singh, MD, MPH Assistant Professor Key messages Systematic reviews (SR) summarize
More informationShould beta blockers remain first-line drugs for hypertension?
1 de 6 03/11/2008 13:23 Should beta blockers remain first-line drugs for hypertension? Maros Elsik, Cardiologist, Department of Epidemiology and Preventive Medicine, Monash University and The Alfred Hospital,
More informationEFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION
EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION Khemchandani D. 1 and * Arif A. Faruqui 2 1 Bairagarh,
More informationApparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments
ORIGINAL ARTICLE doi: 10.1111/j.1472-8206.2005.00356.x Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments Jean-Pierre Boissel a *, François
More informationQuality of Clinical Practice Guidelines
Evidence Based Dentistry Quality of Clinical Practice Guidelines Asbjørn Jokstad University of Oslo, Norway 23 Aug 2001 1 PRACTICE GUIDELINES IN MEDLINE 1400 >1300 1200 1000 800 815 600 592 400 374 200
More informationEQUATOR Network: promises and results of reporting guidelines
EQUATOR Network: promises and results of reporting guidelines Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK Key principles of research publications A published research
More informationBest Practices in Cardiac Care: Getting with the Guidelines
Best Practices in Cardiac Care: Getting with the Guidelines December 9, 2014 Agenda Cardiovascular Disease: How do the guidelines fit into an implementation scheme? What the guidelines set out to accomplish
More informationMadhukar Pai, MD, PhD Associate Professor Department of Epidemiology & Biostatistics McGill University, Montreal, Canada
Madhukar Pai, MD, PhD Associate Professor Department of Epidemiology & Biostatistics McGill University, Montreal, Canada Email: madhukar.pai@mcgill.ca Readers often look to the Reviewers discussion and
More informationHowever, if instead, CHD risk is plotted on a doubling scale (as in slide 2) then there is a
Slides 1 and 2: These two illustrative slides (based on notionaldata) were used in my presentation to Dr Godlee at our meeting on 2 December 2013 to show that, if the risk of coronary disease (CHD) is
More informationManuscript ID BMJ R1 entitled "Education and coronary heart disease: a Mendelian randomization study"
BMJ - Decision on Manuscript ID BMJ.2017.03 7504.R1 Body: 11-May-2017 Dear Dr. Tillmann Manuscript ID BMJ.2017.037504.R1 entitled "Education and coronary heart disease: a Mendelian randomization study"
More informationChecklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews
The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Randomized Controlled Trials http://joannabriggs.org/research/critical-appraisal-tools.html www.joannabriggs.org
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More information